Back

Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease

13 April 2024 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Novel targets in atherosclerosis Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Annelie Shami

Lund University, Malmo (Sweden)

3 More presentations in this session

Presentation thumbnail
anti-interleukin-18 as therapy against atherosclerosis
Associate Professor I. Bot (Leiden, NL)
Abstract
Presentation thumbnail
The calcium-sensing-receptor (CaSR) in adipocytes contributes to sex-differences in the susceptibility to high fat diet induced obesity and atherosclerosis
Doctor S. Maas (Aachen, DE)
Abstract
Presentation thumbnail
Human atherosclerotic plaque macrophages associate with clinical presentation and follow diverse lineage differentiation routes
Doctor K. Prange (Amsterdam, NL)
Abstract

Access the full session

Session thumbnail
Novel targets in atherosclerosis

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 00:00 CET
You may be interested in
thumbnail
Congress Presentation
LIGHT/TNFSF14 levels in carotid atherosclerotic plaques are associated with symptomatic cerebrovascular disease
thumbnail
Congress Presentation
Tumor necrosis factor superfamily 14 (TNFSF14/ LIGHT) attenuates neovascularization by reducing circulating endothelial progenitor cells and function
thumbnail
Congress Presentation
Prediction of cardiovascular outcomes by subtle changes in the peripheral immune cell landscape - insights from the LURIC single cell RNA-sequencing study (LuRNA)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources